scholarly journals Subclinical Hyperthyroidism is One of the Modifiable Risk Factors for Atrial Fibrillation

2021 ◽  
Vol 000 (000) ◽  
pp. 000-000
Author(s):  
Milovan M. Stojanovic ◽  
Vidosava S. Stojanovic ◽  
Duska C. Stojanovic
2020 ◽  
Vol 2 (55) ◽  
pp. 14-19
Author(s):  
Agnieszka Wojdyła-Hordyńska ◽  
Grzegorz Hordyński

Atrial fibrillation is one of the most common arrhythmias, with a significant increase in incidence in recent years. AF is a major cause of stroke, heart failure, sudden cardiac death, and cardiovascular disease. Timely intervention and modification of risk factors increase chance to stop the disease. Aggressive, multilevel prevention tactics are a component of combined treatment, including – in addition to lifestyle changes, anticoagulant therapy, pharmacotherapy and invasive anti-arrhythmic treatment – prevention of cardiovascular diseases, hypertension, ischemia, valvular disease and heart failure.


Author(s):  
Satoshi Matsuoka ◽  
Hidehiro Kaneko ◽  
Akira Okada ◽  
Kojiro Morita ◽  
Hidetaka Itoh ◽  
...  

Circulation ◽  
2018 ◽  
Vol 137 (14) ◽  
pp. 1528-1529 ◽  
Author(s):  
Michael Spartalis ◽  
Eleni Tzatzaki ◽  
Eleftherios Spartalis

Anaesthesia ◽  
2016 ◽  
Vol 71 (12) ◽  
pp. 1424-1430 ◽  
Author(s):  
S. H. Lee ◽  
H. J. Ahn ◽  
S. M. Yeon ◽  
M. Yang ◽  
J. A. Kim ◽  
...  

Circulation ◽  
2017 ◽  
Vol 136 (6) ◽  
pp. 583-596 ◽  
Author(s):  
Dennis H. Lau ◽  
Stanley Nattel ◽  
Jonathan M Kalman ◽  
Prashanthan Sanders

2019 ◽  
Vol 57 (2) ◽  
pp. 99-109 ◽  
Author(s):  
Alireza Sepehri Shamloo ◽  
Nikolaos Dagres ◽  
Arash Arya ◽  
Gerhard Hindricks

Abstract Atrial fibrillation (AF), as the most common cardiac arrhythmia worldwide, is associated with increased mortality and morbidity. Successful therapeutic strategies have been introduced so far, but they are associated with significant costs. Therefore, identification of modifiable risk factors of AF and the development of appropriate preventive strategies may play a substantial role in promoting community health and reducing health care system costs. Modifiable cardiovascular risk factors including obesity, hypertension, diabetes mellitus, obstructive sleep apnea, alcohol consumption, smoking, and sedentary lifestyles have been proposed as possible contributors to the development and progression of AF. In this review, we discuss the role of modifiable risk factors in the development and management of AF and the evidence for the underlying mechanism for each of the potential risk factor.


2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
K.M Stout ◽  
H Tandon ◽  
R Adomako ◽  
J.W Schleifer ◽  
J Payne ◽  
...  

Abstract Background/Introduction Obesity and atrial fibrillation (AF) coexist and share multiple cardiovascular risk factors. Lifestyle modifications can reduce AF burden in obese patients. However, the time invested in pursing lifestyle changes may delay AF ablation, which could negate the procedural benefit. Purpose To examine the effects of lifestyle modifications and the timing of catheter ablation on morbidly obese patients with AF. Methods This retrospective study included 217 consecutive AF patients with a body mass index (BMI) ≥35 kg/m2 undergoing AF ablation at a tertiary care center from 2012 to 2019. Modifiable risks were examined, including the time from AF diagnosis to ablation, fluctuation of BMI >5% or an increase in BMI >3% prior to ablation, mean systolic blood pressure >130 mmHg or diastolic blood pressure >80 mmHg, obstructive sleep apnea with CPAP noncompliance, hyperlipidemia without statin therapy, tobacco use, excessive alcohol use, and diabetes mellitus with hemoglobin A1c (HbA1c) ≥6.5%. The primary outcome was a composite of recurrent atrial arrhythmias and cardiovascular (CV) hospitalizations following AF ablation. A multivariate analysis adjusting for age, gender and modifiable risks was performed. Results The mean age was 61±9 years old, 58% were female and 45% had persistent AF. A substantial portion of the study patients had modifiable risk factors, ranging from 2.7% with excessive alcohol use to 67.3% experiencing delayed AF ablation, Figure 1. The median time from diagnosed AF to ablation was 1.3 years. During a mean follow-up of 2.9 years after AF ablation, 136 (62.7%) patients met the primary outcome. Only HbA1c ≥6.5% was an independent risk factor with adjusted hazard ratio of 1.57, 95% confidence interval 1.02–2.36, P=0.0412, Figure 2A. Delayed AF ablation did not alter the outcome, Figure 2B. There was no interaction between time of ablation and HbA1c ≥6.5% (P=0.67). Conclusion Substantial portions of morbidly obese patients undergoing AF ablation have potentially modifiable risk factors. Poor glycemic control with HbA1c ≥6.5% predicts an increased risk of recurrent atrial arrhythmias and CV hospitalizations, while delayed AF ablation does not. This finding underscores an importance of optimizing HbA1c in morbidly obese patients with AF to reduce adverse outcomes after ablation. FUNDunding Acknowledgement Type of funding sources: None.


Circulation ◽  
2018 ◽  
Vol 137 (14) ◽  
pp. 1534-1535 ◽  
Author(s):  
Dennis H. Lau ◽  
Stanley Nattel ◽  
Jonathan M. Kalman ◽  
Prashanthan Sanders

Sign in / Sign up

Export Citation Format

Share Document